Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity. |
eNq1mFFv2jAQx9/5FFHeSQgr0E6BamOwIbUao0Wb9lKZ5ACzYKdnG+g+/RxCNTo56mrwY2znfxff3z+fEl/v1pm3ARSUs64fBQ3fA5bwlLJF15/eD+uX/nWvFq/Ihhwt6wSNIGr6XpIRIbp+MRvMgDAR/Li9+QT6fUC/V/NiPltBIl+sU5JmwRcilrckL9Z48YbT1FuDXPK06+dK7ke9WEjUWfS2HH+JnCQQh4eR49nVw8XxeBwWYv+hqgTgDWELoygwK81EIQKTfSJhwfGpIt93VtpUTEBwhQmMiVyOkW9oCqkxxJxkAqyCzLfpHeAmA1kEMYqHq2QtrMTJiuwm8DgyJ/1Bz/blTtYb9ajTbkad1kUUXUZNq1B4tFXmKuiPCJOHTrPVjK5CYOGaLBjUZ23L2ow5SpI5qgoV/ZfGchQH4fHV6qdU5Bl5ClYit90qgkRPA+rj7+5Dii+4Rw2kTO/ZP/pMZVn4xqynB1w4yrigUZ8rJiuoMZzYbkSfMwm76oragU7uDl6kIM4n+5szM+THapbRxBZpGjoKhJxORtVEOycMPhIBU3RHg++UpXwrzk+Z46o6yj7fg9IommMaPTSvLttRq2V9iH5qC1XcMAOFPIdQ84eKU7AyYnN+KlC0K81Sz548mx33fQ5PSAYVnU7dki3ah8+NmTOnuztF5YRR9PPg3tYe3xTg093+0ShN0+5zYe246wLm2ouVeb/d2eUBd9ICKzSDYyllLt6H4Xa7DZZE1AXRuxTM8exgP7pL3TXgTi7ssoEp4ego9Vl5672tQrYH7bUr/dQ29fD+oR02xpCo4IRalEx2Rs7R4Pww/tujOkt7/IIe7sLs+0kiKWeu+hw1MyqehH9dVjZEzYev8zmt+B9Sacs4LP/F9GpxWPyH6dX+AD0j4vQ=
7DbCy6gGHRgnV8D7
Listen
